Literature DB >> 34246454

[Human immunodeficiency virus and lymphoma].

Illias Tazi1, Fatima Zahra Lahlimi2.   

Abstract

Lymphomas remain a leading cause of morbidity and mortality for HIV-positive patients. The most common lymphomas include diffuse large B-cell lymphoma, Burkitt lymphoma, primary effusion lymphoma, plasmablastic lymphoma and Hodgkin lymphoma. Appropriate approach is determined by lymphoma stage, performans status, comorbidities, histological subtype, status of the HIV disease and immunosuppression. Treatment outcomes have improved due to chemotherapy modalities and effective antiretroviral therapy. This review summarizes epidemiology, pathogenesis, pathology, and current treatment landscape in HIV associated lymphoma.
Copyright © 2021 Société Française du Cancer. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  AIDS; Antiretroviral therapy; HIV; Hodgkin lymphoma; Lymphome de Hodgkin; Lymphome non Hodgkinien; Non-Hodgkin's lymphoma; SIDA; Traitement antirétroviral; VIH

Year:  2021        PMID: 34246454     DOI: 10.1016/j.bulcan.2021.03.014

Source DB:  PubMed          Journal:  Bull Cancer        ISSN: 0007-4551            Impact factor:   1.276


  1 in total

1.  A Rare Case of Plasmablastic Lymphoma in a Patient with HIV and SARS-CoV-2 Infections.

Authors:  Adriana Teodora Campeanu; Elena Dumea; Mihaela Rus; Claudia Fodor; Anita Cristina Ionescu; Elena Mocanu; Mihaela Botnarciuc; Irina Magdalena Dumitru
Journal:  Curr Oncol       Date:  2022-03-02       Impact factor: 3.677

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.